Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/119758
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHall, R.en
dc.contributor.authorBirrell, S.en
dc.contributor.authorTilley, W.en
dc.contributor.authorSutherland, R.en
dc.date.issued1994en
dc.identifier.citationEuropean Journal of Cancer, 1994; 30A(4):484-490en
dc.identifier.issn0959-8049en
dc.identifier.issn1879-0852en
dc.identifier.urihttp://hdl.handle.net/2440/119758-
dc.description.abstractThe role of androgens and the androgen receptor (AR) in the development and progression of breast cancer is poorly understood. To further define a potential model for androgen action in breast cancer, MDA-MB-453 cells, which express AR in the absence of oestrogen receptors and progesterone receptors, were further characterised in terms of AR expression and androgen responsiveness. High level expression of AR was confirmed by northern blot analysis, radioligand binding and immunocytochemistry, and could not be accounted for by AR gene amplification. Three endogenous androgen-responsive genes (fatty acid synthetase, gross cystic disease fluid protein of 15 kDa and prolactin receptor) and a transfected reporter gene, containing an androgen-responsive element, were induced following androgen administration. A synthetic androgen, mibolerone, induced moderate (27% above control) stimulation of MDA-MB-453 cell proliferation, which was abrogated by the simultaneous administration of the synthetic androgen antagonist, anandron, demonstrating that the effect was AR-mediated. In summary, MDA-MB-453 cells express high levels of functional AR, and thus provide a valuable in vitro model for further studies on androgen regulation of gene expression, and perhaps cell proliferation in breast cancer.en
dc.description.statementofresponsibilityR.E.Hall, S.N.Birrell, W.D.Tilley, R.L.Sutherlanden
dc.language.isoenen
dc.publisherElsevieren
dc.rights© 1994 Published by Elsevier Ltd.en
dc.subjectAndrogen action; breast cancer; androgen receptoren
dc.titleMDA-MB-453, an androgen-responsive human breast carcinoma cell line with high level androgen receptor expressionen
dc.typeJournal articleen
dc.identifier.rmid0030072812en
dc.identifier.doi10.1016/0959-8049(94)90424-3en
dc.identifier.pubid362066-
pubs.library.collectionMedicine publicationsen
pubs.library.teamDS10en
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
dc.identifier.orcidTilley, W. [0000-0003-1893-2626]en
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.